PODD Stock Analysis: Buy, Sell, or Hold?
PODD - Insulet Corporation
$169.70
4.35 (2.63%)
▲
5d:
+2.85%
30d:
+3.17%
90d:
-3.05%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 05, 2026
TODAY
Get Alerted When PODD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: PODD shows positive signals but monitor for confirmation. Market pricing in 11.3% decline. Moderate conviction.
💡 BUY OPPORTUNITY: PODD shows positive signals but monitor for confirmation. Market pricing in 11.3% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$386.41
Based on 14.2% avg growth
INTRINSIC VALUE TODAY
$239.93
29.3% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: PODD is currently trading at $169.70, which is considered extended relative to its 30-day fair value range of $157.42 to $166.22. From a valuation perspective, the stock is trading at a discount (Forward PE: 21.2) compared to its historical average (30.4). Remarkably, the market is currently pricing in an annual earnings decline of 11.3% over the next few years. This pessimistic expectation contrasts with the company's recent 159.0% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, PODD is in a strong downtrend. The price is approaching resistance at $172.91. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: PODD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $235.54 (+38.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, PODD is in a strong downtrend. The price is approaching resistance at $172.91. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: PODD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $235.54 (+38.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$157.42 -
$166.22
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 38.1% below Wall St target ($235.54)
Trading Range Analysis
30-Day Trading Range
$157.42 -
$166.22
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$157.44
Resistance Level
$172.92
Current Trend
Strong Downtrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
21.18
Wall Street Target
$235.54
(+38.1%)
Revenue Growth (YoY)
33.9%
Earnings Growth (YoY)
159.0%
Profit Margin
10.4%
Valuation Discount vs History
-11.3% cheaper
PE vs Historical
21.2 vs 30.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-11.3%
(market-implied from PE analysis)
1-Year Target
$153.56
(-10%)
2-Year Target
$138.20
(-19%)
3-Year Target
$124.38
(-27%)
3-Yr Target (if PE normalizes)
(PE: 21→30)
$178.50
(+5%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.2, Growth: 24.3%)
$327.30
(+92%)
Base:
(SPY PE: 20.8, Growth: 24.3%)
$321.53
(+88%)
Bear:
(PE: 17.7, Growth: 24.3%)
$273.30
(+60%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (39x PE), but valuation improves significantly next year (21x PE) as earnings recover.
Trailing PE: 38.59 | Current EPS (TTM): $4.34
Bull Case
$341.88
(+102%)
Analyst growth 85.6%, PE expands to 42.5
Base Case
$310.80
(+83%)
Market implied 85.6%, PE stable at 38.6
Bear Case
$113.88
(-33%)
Severe decline -20.0%, PE contracts to 32.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 21.2 to 30.4
Stabilization Target:
$244.85
(+43.5%)
PE Expansion Potential:
+43.5%
Share & Embed Analysis
Last updated: August 04, 2026 12:00 AM ET
Data refreshes hourly during market hours. Next update: 1:00 AM
Data refreshes hourly during market hours. Next update: 1:00 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PODD showing a specific setup today?
Insider Activity (6 Months)
2
Buys
1
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Michael R Minogue
BUY
2030 shares
2026-02-25
Ro Khanna
SELL
2026-02-24
Ro Khanna
BUY
2026-02-17
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$93 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$384 | 51 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 52 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 57 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 52 HOLD |
Advanced PODD Option Strategies
Professional options setups generated by AI based on today's PODD price and gamma walls.
